Virus-cell Fusion Inhibitory Activity for the Polysaccharides from Various Korean Edible Clams

Archives of Pharmacal Research

Volumn 24, Issue 6, 2001, Pages 514-517

  Woo, Eun Rhan ^a   Kim, Wan Seok ^b   Kim, Yeong Shik ^b  

^a Chosun University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Anti hiv; Clams; Fusion; Gp120 41; Syncytia

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; POLYSACCHARIDE;

ANIMAL; ARTICLE; BIVALVE; CHEMISTRY; DRUG EFFECT; HELA CELL; HUMAN; ISOLATION AND PURIFICATION; MEMBRANE FUSION;

ANIMALS; ANTI-HIV AGENTS; BIVALVIA; HELA CELLS; HUMANS; MEMBRANE FUSION; POLYSACCHARIDES;

EID: 0035748643     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02975155     Document Type: Article

References (23)

1. Amornrut, C., Toida, T., Imanari, T., Woo, E. -R, Park, H., Linhardt,. R., Wu, S. J, Kim, Y. S., A new sulfated β- galactan from clams with anti-HIV activity. Carbohydr. Res. 32, 121-7 (1999).
2. Cheserbo, B., and Wehrly, K., Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. J. Virol., 62, 3779-3788 (1988).
3. De Clercq, E., Suramin in the treatment of AIDS: mechanism of action. Antiviral Res., 7, 1-10 (1987).
4. De Clercq E., HIV resistance to reverse transcriptase inhibitors. Biochem. Pharmacol., 47, 155-169 (1994).
5. De Clercq E., Antiviral therapy for human immunodeficiency virus infections. Clin. Microbiol. Rev., 8, 200- 239 (1995).
6. Earl, P. L., Hugin, A. W., and Moss, B., Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus. J. Virol., 64, 2448-2451 (1990).
7. Faulds, D., and Brogden, R. N., Didanosine. a review of its antiviral activity, pharmacokinetic properties and therapeutic potential in human immunodeficiency virus infection. Drugs, 44, 94-116 (1992).
8. Hart, T. K., Kirsh, R., Ellens, H., Sweet, R. W., Lambert, D. M., Petteway, S. R., Leary, J., and Bugelski, P. J., Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA, 88, 2189-2193 (1991).
9. Kim, Y. S. Jo, Y. Y., Chang, I. -M., Toida, T., Park, Y. M. Linhardt, R. J., A New Glycosaminoglycan from the Giant African Snail from Achatina fulica. J. Biol. Chem., 271, 1750-11755 (1996).
10. Kim, H. J., Woo, E. -R., Shin, C. -G., and Park, H., A new flavonol glycoside gallate from Acer okamotoanum and its inhibitory activity against human immunodeficiency virus (HIV) integrase. J. Nat. Prod., 61, 145-148 (1998).
11. Kim, H. J., Lee, J. S., Woo, E. -R., Kim, M. K., Yang, B. S., Yu, Y. G., Park, H., and Lee, Y. S., Isolation of virus-cell fusion inhibitory components from Eugenia caryophyllata. Planta med., 67, 99-102 (2001).
12. Langtry, H. D., and Campoli-Richards, D. M., Zidobudine, a review of its pharmacodynamic and pharmacokinetic properities, and therapeutic efficacy. Drugs, 37, 408-450 (1989).
13. Lin, P. -F., Samanta, H., Bechtold, C. M., Deminie, C. A., Patick, A. K., Alam, M., Riccardi, K., Rose, R. E., White, R. J., and Colonno, R. J., Characterization of siamycin 1, a human immunodeficiency virus fusion inhibitor. Antimicrob. Agents Chemother., 40, 133-138 (1996).
14. Mayaux, J. -F., Bousseau, A., Pauwels R., Huet, T., Henin, Y., Dereu, N., Evers, M., Soler F., Poujade, C., De Clercq E., and Le Pecq J. -B., Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells. Proc. Natl. Acad. Sci. USA, 91, 3564-3568 (1994).
15. Nakashima H., Ichiyama, K., Inazawa, K., Ito, M., Hayashi, H., Nishihara, Y., Tsujii, E., and Kino, T., FR901724, a novel anti-human immunodeficiency virus (HIV) peptide produced by Streptomyces, shows synergistic antiviral activities with HIV protease inhibitor and 2, 3-dideoxy- nucleosides. Biol. Pharm. Bull., 19, 405-412 (1996).
16. Pereira, F. B., Goni, F. M., and Nieva J. L., Liposome destabilization induced by the HIV-1 fusion peptide effect of a single amino acid substitution. FEBS Letters, 362, 243-246 (1995).
17. Ryu, J. -R., Jin, B. -S., Suh, M. -J., Yoo, Y -S., Yoon, S. H., Woo, E. -R., and Yu, Y. C., Two interaction modes of the gp41-derived peptides with gp41 and their correlation with antimembrane fusion activity. Biochem. Biophys. Res. Commun., 265, 625-629 (1999).
18. Ryu, J. -R., Lee, J., Choo, S., Yoon, S. H., Woo, E. -R., and Yu, Y. G., Development of an in vitro assay system for screening of gp 41 inhibitory compounds. Mol. Cells., 8, 717-723 (1998).
19. Tochikura, T. S., Nakashima, H., Tanabe, A., Yamamoto, N., Human immunodeficiency virus (HIV)-induced cell fusion: Quantification and its application for the simple and rapid screening of anti-HIV substances in vitro. Virol., 164, 542-546 (1988).
20. Whittington, R., and Brogden, R. N., Zalcitabine, a review of its pharmacology and clinical potential in acquired immunodeficiency syndrome (AIDS). Drugs, 44, 656- 683 (1992).
21. Woo, E. -R., Yoon, S. H., Kwak, J. H., Kim, H. J., and Park, H., Inhibition of gp120-CD4 interaction by various plant extracts. Phytomedicine, 4, 53-58 (1997).
22. Wu, S. J. Chun, M. W., Shin, K. H., Toida, T., Park, Y., Linhardt, R.J., and Kim, Y. S, Chemical oversulfation and anticoagulant activity of acharan sulfate. Thromb. Res., 92, 273-281 (1998).
23. Yao, X-J., Wainberg, M. A., and Parniak, M. A., Mechanism of inhibition of HIV-1 in vitro by purified extracts of Prunella vulgaris. Virol., 187, 56-62 (1992).